IL138626A0 - Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily - Google Patents

Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily

Info

Publication number: IL138626A0
Authority: IL; Israel
Prior art keywords: mflint; opg3; polypeptides; therapeutic applications; receptor superfamily
Prior art date: 1998-03-30

Application number

IL13862699A

Other languages

English (en)

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-30

Filing date

1999-03-30

Publication date

2001-10-31

1999-03-30 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-10-31 Publication of IL138626A0 publication Critical patent/IL138626A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Zoology (AREA)
Toxicology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IL13862699A 1998-03-30 1999-03-30 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily IL138626A0 (en)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US7985698P	1998-03-30	1998-03-30
US8607498P	1998-05-20	1998-05-20
US9964398P	1998-09-09	1998-09-09
US11257798P	1998-12-17	1998-12-17
US11270398P	1998-12-18	1998-12-18
US11293398P	1998-12-18	1998-12-18
US11340798P	1998-12-22	1998-12-22
PCT/US1999/006797 WO1999050413A2 (en)	1998-03-30	1999-03-30	THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY

Publications (1)

Publication Number	Publication Date
IL138626A0 true IL138626A0 (en)	2001-10-31

Family

ID=27568394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13862699A IL138626A0 (en)	1998-03-30	1999-03-30	Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily

Country Status (16)

Country	Link
US (1)	US20040167074A1 (pt)
JP (1)	JP2002512006A (pt)
KR (1)	KR20010042364A (pt)
CN (1)	CN1303429A (pt)
AU (1)	AU3369199A (pt)
BR (1)	BR9909328A (pt)
CA (1)	CA2324517A1 (pt)
CZ (1)	CZ20003433A3 (pt)
EA (1)	EA200001004A1 (pt)
HU (1)	HUP0102067A2 (pt)
ID (1)	ID27820A (pt)
IL (1)	IL138626A0 (pt)
NO (1)	NO20004873L (pt)
PL (1)	PL343847A1 (pt)
TR (1)	TR200002824T2 (pt)
WO (1)	WO1999050413A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20000070174A (ko)	1997-01-14	2000-11-25	벤슨 로버트 에이치.	종양 괴사 인자 수용체 6α 및 6β
US7285267B2 (en)	1997-01-14	2007-10-23	Human Genome Sciences, Inc.	Tumor necrosis factor receptors 6α & 6β
DK1015587T3 (da)	1997-09-18	2008-08-25	Genentech Inc	DcR3 polypeptid, en TNFR-homolog
CA2358508A1 (en) *	1998-12-22	2000-06-29	Eli Lilly And Company	Therapeutic applications of flint polypeptides
DE60036199T2 (de) *	1999-03-30	2008-05-21	Eli Lilly And Co., Indianapolis	Proteaseresistente flint-analoge
US6627199B1 (en)	1999-07-09	2003-09-30	Amgen Inc	Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
AU6517800A (en)	1999-08-04	2001-03-05	Amgen, Inc.	Ntr3, a member of the tnf-receptor supergene family
JP2003506088A (ja)	1999-08-04	2003-02-18	アムジェンインコーポレーテッド	ＴＮＦリガンドスーパー遺伝子ファミリーの新規のメンバーであるＦｈｍ
WO2001018041A2 (en) *	1999-09-10	2001-03-15	Eli Lilly And Company	Flint proteins and formulations thereof
AU1189101A (en) *	1999-10-20	2001-04-30	Eli Lilly And Company	Therapeutic applications of flint polypeptides
AU1915201A (en) *	1999-12-07	2001-06-18	Eli Lilly And Company	Improving stability of flint through o-linked glycosylation
WO2002018622A2 (en) *	2000-08-25	2002-03-07	Human Genome Sciences, Inc.	TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
CA2439193A1 (en) *	2001-02-23	2002-08-29	Hideki Matsui	Casoase 3 inhibitors
CA2520138C (en)	2003-03-26	2017-05-23	Apogenix Gmbh	Improved fc fusion proteins
WO2006072137A1 (en) *	2005-01-07	2006-07-13	Northern Sydney And Central Coast Area Health Service	Treatment for autoimmune and inflammatory conditions
DK2428252T3 (en)	2006-12-28	2015-02-16	Deutsches Krebsforsch	Neutralization of the effect of CD95 to block the invasion of glioblastoma cells in vivo
EP2318441A2 (en) *	2008-07-14	2011-05-11	Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts	Use of cd95 inhibitors for the treatment of inflammatory disorders
CN102671186B (zh) *	2011-09-19	2014-08-06	上海市肿瘤研究所	促造血的药物组合物及其应用
ES2589134T3 (es)	2012-07-18	2016-11-10	Apogenix Ag	Inhibidores de la ruta de señalización de CD95 para el tratamiento de MDS
EP3076179A1 (en)	2015-03-30	2016-10-05	Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts	Diagnosis and treatment of low grade gliomas
CN108463236A (zh)	2015-12-18	2018-08-28	泰伦基国际有限公司	一种预防或治疗放射性和化学性损伤的方法
EP3395355A4 (en)	2015-12-18	2019-06-12	Talengen International Limited	METHOD FOR PREVENTING AND TREATING ZERVIXEROSINE
JP7760374B2 (ja)	2019-03-29	2025-10-27	ターンストーンバイオロジクスコーポレイション	Ｔ細胞治療薬を生成するためのエクスビボ方法ならびに関連する組成物および方法
EP4065229A1 (en)	2019-11-27	2022-10-05	Myst Therapeutics, LLC	Method of producing tumor-reactive t cell composition using modulatory agents
AU2021226903A1 (en)	2020-02-27	2022-10-20	Turnstone Biologics Corp.	Methods for ex vivo enrichment and expansion of tumor reactive T cells and related compositions thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20000070174A (ko) *	1997-01-14	2000-11-25	벤슨 로버트 에이치.	종양 괴사 인자 수용체 6α 및 6β
US5885800A (en) *	1997-02-04	1999-03-23	Smithkline Beecham Corporation	DNA encoding tumor necrosis related receptor, TR4
WO1999004001A1 (en) *	1997-07-21	1999-01-28	Zymogenetics, Inc.	Tumor necrosis factor receptor ztnfr-5
JP2001512667A (ja) *	1997-08-06	2001-08-28	リジェネロン・ファーマシューティカルズ・インコーポレイテッド	ヒトオーファンレセプターｎｔｒ−１
DK1015587T3 (da) *	1997-09-18	2008-08-25	Genentech Inc	DcR3 polypeptid, en TNFR-homolog
WO1999026977A1 (en) *	1997-11-24	1999-06-03	Biogen, Inc.	Novel receptors opg-2

1999
- 1999-03-30 IL IL13862699A patent/IL138626A0/xx unknown
- 1999-03-30 WO PCT/US1999/006797 patent/WO1999050413A2/en not_active Ceased
- 1999-03-30 HU HU0102067A patent/HUP0102067A2/hu unknown
- 1999-03-30 CN CN99806639A patent/CN1303429A/zh active Pending
- 1999-03-30 PL PL99343847A patent/PL343847A1/xx unknown
- 1999-03-30 KR KR1020007010929A patent/KR20010042364A/ko not_active Withdrawn
- 1999-03-30 TR TR2000/02824T patent/TR200002824T2/xx unknown
- 1999-03-30 JP JP2000541301A patent/JP2002512006A/ja not_active Withdrawn
- 1999-03-30 ID IDW20001948A patent/ID27820A/id unknown
- 1999-03-30 CZ CZ20003433A patent/CZ20003433A3/cs unknown
- 1999-03-30 EA EA200001004A patent/EA200001004A1/ru unknown
- 1999-03-30 BR BR9909328-6A patent/BR9909328A/pt not_active Application Discontinuation
- 1999-03-30 AU AU33691/99A patent/AU3369199A/en not_active Abandoned
- 1999-03-30 CA CA002324517A patent/CA2324517A1/en not_active Abandoned
2000
- 2000-09-28 NO NO20004873A patent/NO20004873L/no unknown
2004
- 2004-03-04 US US10/793,269 patent/US20040167074A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HUP0102067A2 (hu)	2001-10-28
ID27820A (id)	2001-04-26
NO20004873D0 (no)	2000-09-28
JP2002512006A (ja)	2002-04-23
CZ20003433A3 (cs)	2001-10-17
TR200002824T2 (tr)	2000-12-21
CN1303429A (zh)	2001-07-11
NO20004873L (no)	2000-11-24
BR9909328A (pt)	2000-12-12
EA200001004A1 (ru)	2001-06-25
WO1999050413A2 (en)	1999-10-07
PL343847A1 (en)	2001-09-10
WO1999050413A3 (en)	1999-12-02
US20040167074A1 (en)	2004-08-26
AU3369199A (en)	1999-10-18
CA2324517A1 (en)	1999-10-07
KR20010042364A (ko)	2001-05-25

Publication	Publication Date	Title
IL138626A0 (en)	2001-10-31	Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the receptor superfamily
AU5923398A (en)	1998-08-07	Polynucleotides and polypeptides encoding receptors
AU5274499A (en)	2000-03-06	Therapeutic chemokine receptor antagonists
PT1090128E (pt)	2008-04-17	Polipéptidos dependentes da vitamina k modificados
GB9724783D0 (en)	1998-01-21	Novel polypeptides
EP1041888A4 (en)	2000-10-18	ANTIRETROVIRAL IMMUNOGENS, PREPARATION AND USE THEREOF
AU8673198A (en)	1999-02-22	Il-8 receptor antagonists
AU5733898A (en)	1998-08-07	Member of the hematopoietin receptor superfamily
GB2331184B (en)	1999-09-22	Thermally responsive switch
IL133920A0 (en)	2001-04-30	Trail receptor
AU2001295412A1 (en)	2002-01-30	A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide
AU6435098A (en)	1998-08-26	Il-8 receptor antagonists
AU3739400A (en)	2000-10-16	Flint polypeptide analogs
PL337722A1 (en)	2000-08-28	Novel combination antiasthmatic drugs
GB9726539D0 (en)	1998-02-11	Polypeptides, polynucleotides and uses thereof
AU4411699A (en)	1999-12-20	Interferon receptor hkaef92
EP1005489A4 (en)	2002-09-25	NEW POLYPEPTIDES FROM THE GROWTH FACTOR FAMILY
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
GB9717416D0 (en)	1997-10-22	Polypeptides,polynucleotides and uses thereof
GB2318456B (en)	1998-09-23	Safety switch
GB9722273D0 (en)	1997-12-17	Therapeutic polypeptides
AU7743801A (en)	2001-11-12	A novel polypeptide, a hman central receptor of cannabinoide 9 and the polynucleotide encoding the polypeptide
AU4630101A (en)	2001-09-12	A novel polypeptide, a human cytokine receptor 12 and the polynucleotide encoding the polypeptide
HUP0102540A3 (en)	2003-09-29	Novel angiotensin receptor, production and use thereof
TW357915U (en)	1999-05-01	Dual joystick controlling device